The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on the company’s Marketing Authorization Application (MAA) for HIV-1 drug candidate Biktarvy. Biktarvy is a combination of […]
China-based WuXi Biologics is set to construct a biologics drug substance manufacturing facility worth about €325m in Dundalk, Ireland. The construction of the company’s first site outside of China is supported by the Irish Government […]
Karyopharm Therapeutics’ selinexor, an oral selective inhibitor of nuclear export (SINE) compound, has succeeded in a phase 2b study by showing a 25.4% overall response rate (ORR) in heavily pretreated patients with refractory multiple myeloma. […]